Correlation of p53 over-expression and alteration in p53 gene detected by polymerase chain reaction-single strand conformation polymorphism in adenocarcinoma of gastric cancer patients from India

World Journal of Gastroenterology

Volumn 15, Issue 11, 2009, Pages 1381-1387

  Karim, Sajjad ^a,b   Ali, Arif ^a  

^a JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Gastric cancer; Gene mutation; Immunohistochemistry; P53; Single strand conformation polymorphism

Indexed keywords

PROTEIN P53; DNA;

ADULT; AGED; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; DISEASE MARKER; EXON; FEMALE; GENE MUTATION; GENE OVEREXPRESSION; GENETIC STABILITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INDIA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; STOMACH ADENOCARCINOMA; ADENOCARCINOMA; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENETICS; ISOLATION AND PURIFICATION; METHODOLOGY; MUTATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REFERENCE VALUE; STOMACH; STOMACH MUCOSA; STOMACH TUMOR; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; DNA, NEOPLASM; EXONS; GASTRIC MUCOSA; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; INDIA; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; REFERENCE VALUES; STOMACH; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 65649084790     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.1381     Document Type: Article

References (49)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108
2. Rao DN, Ganesh B, Dinshaw KA, Mohandas KM. A case-control study of stomach cancer in Mumbai, India. Int J Cancer 2002; 99: 727-731
3. Sasagawa T, Solano H, Mena F. Gastric cancer in Costa Rica. Gastrointest Endosc 1999; 50: 594-595; discussion 595-596
4. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003; 53: 5-26
5. Bani-Hani KE, Yaghan RJ, Heis HA, Shatnawi NJ, Matalka II, Bani-Hani AM, Gharaibeh KA. Gastric malignancies in Northern Jordan with special emphasis on descriptive epidemiology. World J Gastroenterol 2004; 10: 2174-2178
6. Mohandas KM, Jagannath P. Epidemiology of digestive tract cancers in India. VI. Projected burden in the new millennium and the need for primary prevention. Indian J Gastroenterol 2000; 19: 74-78
7. Lee WJ, Lee WC, Houng SJ, Shun CT, Houng RL, Lee PH, Chang KJ, Wei TC, Chen KM. Survival after resection of gastric cancer and prognostic relevance of systematic lymph node dissection: twenty years experience in Taiwan. World J Surg 1995; 19: 707-713
8. Tahara E, Semba S, Tahara H. Molecular biological observations in gastric cancer. Semin Oncol 1996; 23: 307-315
9. Wu M, Semba S, Li D, Yokozaki H. Molecular pathological analysis of mucinous adenocarcinomas of the stomach. Pathobiology 2004; 71: 201-210
10. Yasui W, Yokozaki H, Fujimoto J, Naka K, Kuniyasu H, Tahara E. Genetic and epigenetic alterations in multistep carcinogenesis of the stomach. J Gastroenterol 2000; 35 Suppl 12: 111-115
11. Werner M, Becker KF, Keller G, Hofler H. Gastric adenocarcinoma: pathomorphology and molecular pathology. J Cancer Res Clin Oncol 2001; 127: 207-216
12. Johnson O, Ersumo T, Ali A. Gastric carcinoma at Tikur Anbessa Hospital, Addis Ababa. East Afr Med J 2000; 77: 27-30
13. Hamdi J, Morad NA. Gastric cancer in southern Saudi Arabia. Ann Saudi Med 1994; 14: 195-197
14. Al-Mofleh IA. Gastric cancer in upper gastrointestinal endoscopy population: Prevalence and clinicopathological characteristics. Ann Saudi Med 1992; 12: 548-551
15. Mohar A, Suchil-Bernal L, Hernandez-Guerrero A, Podolsky-Rapoport I, Herrera-Goepfert R, Mora-Tiscareno A, Aiello-Crocifoglio V. Intestinal type: diffuse type ratio of gastric carcinoma in a Mexican population. J Exp Clin Cancer Res 1997; 16: 189-194
16. Wu CW, Tsay SH, Hsieh MC, Lo SS, Lui WY, P'eng FK. Clinicopathological significance of intestinal and diffuse types of gastric carcinoma in Taiwan Chinese. J Gastroenterol Hepatol 1996; 11: 1083-1088
17. Tamura G, Kihana T, Nomura K, Terada M, Sugimura T, Hirohashi S. Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis. Cancer Res 1991; 51: 3056-3058
18. Renault B, van den Broek M, Fodde R, Wijnen J, Pellegata NS, Amadori D, Khan PM, Ranzani GN. Base transitions are the most frequent genetic changes at P53 in gastric cancer. Cancer Res 1993; 53: 2614-2617
19. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991; 253: 49-53
20. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991; 51: 6304-6311
21. Prokocimer M, Rotter V. Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematologic cell lineages. Blood 1994; 84: 2391-411
22. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989; 5: 874-879
23. Aurello P, D'Angelo F, Rossi S, Bellagamba R, Cicchini C, Nigri G, Ercolani G, De Angelis R, Ramacciato G. Classification of lymph node metastases from gastric cancer: comparison between N-site and N-number systems. Our experience and review of the literature. Am Surg 2007; 73: 359-366
24. Lauren P. The two histological main types of gastric carcinoma, diffuse and so-called intestinal-types carcinoma. An attempt at histochemical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49
25. Campani D, Cecchetti D, Bevilacqua G. Immunocytochemical p53 detection by microwave oven heating of routinely formalin-fixed paraffin sections. J Pathol 1993; 171: 151-152
26. Baas IO, Mulder JW, Offerhaus GJ, Vogelstein B, Hamilton SR. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 1994; 172: 5-12
27. Braggio E, Bonvicino CR, Vargas FR, Ferman S, Eisenberg AL, Seuanez HN. Identification of three novel RB1 mutations in Brazilian patients with retinoblastoma by "exon by exon" PCR mediated SSCP analysis. J Clin Pathol 2004; 57: 585-590
28. Tahara E. Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol 1993; 119: 265-272
29. Seruca R, David L, Castedo S, Veiga I, Borresen AL, Sobrinho-Simoes M. p53 alterations in gastric carcinoma: a study of 56 primary tumors and 204 nodal metastases. Cancer Genet Cytogenet 1994; 75: 45-50
30. Poremba C, Yandell DW, Huang Q, Little JB, Mellin W, Schmid KW, Bocker W, Dockhorn-Dworniczak B. Frequency and spectrum of p53 mutations in gastric cancer - a molecular genetic and immunohistochemical study. Virchows Arch 1995; 426: 447-455
31. Monig SP, Eidt S, Zirbes TK, Stippel D, Baldus SE, Pichlmaier H. p53 expression in gastric cancer: clinicopathological correlation and prognostic significance. Dig Dis Sci 1997; 42: 2463-2467
32. Gomyo Y, Ikeda M, Osaki M, Tatebe S, Tsujitani S, Ikeguchi M, Kaibara N, Ito H. Expression of p21 (waf1/cip1/sdi1), but not p53 protein, is a factor in the survival of patients with advanced gastric carcinoma. Cancer 1997; 79: 2067-2072
33. Wynford-Thomas D. P53 in tumour pathology: can we trust immunocytochemistry? J Pathol 1992; 166: 329-330
34. Kohler MF, Nishii H, Humphrey PA, Saski H, Marks J, Bast RC, Clarke-Pearson DL, Boyd J, Berchuck A. Mutation of the p53 tumor-suppressor gene is not a feature of endometrial hyperplasias. Am J Obstet Gynecol 1993; 169: 690-694
35. Sarnow P, Ho YS, Williams J, Levine AJ. Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell 1982; 28: 387-394
36. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P. Mutations in the p53 gene occur in diverse human tumour types. Nature 1989; 342: 705-708
37. Soussi T. The p53 tumor suppressor gene: from molecular biology to clinical investigation. Ann N Y Acad Sci 2000; 910: 121-137; discussion 137-139
38. Caron de Fromentel C, Soussi T. TP53 tumor suppressor gene: a model for investigating human mutagenesis. Genes Chromosomes Cancer 1992; 4: 1-15
39. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54: 4855-4878
40. Hartmann A, Blaszyk H, McGovern RM, Schroeder JJ, Cunningham J, De Vries EM, Kovach JS, Sommer SS. p53 gene mutations inside and outside of exons 5-8: the patterns differ in breast and other cancers. Oncogene 1995; 10: 681-688
41. Dix B, Robbins P, Carrello S, House A, Iacopetta B. Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas. Br J Cancer 1994; 70: 585-590
42. Wang LD, Zhou Q, Hong JY, Qiu SL, Yang CS. p53 protein accumulation and gene mutations in multifocal esophageal precancerous lesions from symptom free subjects in a high incidence area for esophageal carcinoma in Henan, China. Cancer 1996; 77: 1244-1249
43. Hong SI, Hong WS, Jang JJ, Lee DS, Cho NS, Jung ME, Kim HB, Ha GW, Park IC, Cho DS. Alterations of p53 gene in primary gastric cancer tissues. Anticancer Res 1994; 14: 1251-1255
44. Hayashi K, Yandell DW. How sensitive is PCR-SSCP? Hum Mutat 1993; 2: 338-346
45. Sheffield VC, Beck JS, Kwitek AE, Sandstrom DW, Stone EM. The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. Genomics 1993; 16: 325-332
46. Hayashi K. PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA. PCR Methods Appl 1991; 1: 34-38
47. Hall PA, Lane DP. p53 in tumour pathology: can we trust immunohistochemistry? - Revisited! J Pathol 1994; 172: 1-4
48. Fearon ER, Hamilton SR, Vogelstein B. Clonal analysis of human colorectal tumors. Science 1987; 238: 193-197
49. Scott N, Quirke P. Molecular biology of colorectal neoplasia. Gut 1993; 34: 289-292